|
**Overview**: Macrocytic Anemia Panel**Introduction**: The Macrocytic Anemia Panel is a diagnostic tool designed to screen for macrocytic anemia using serum samples. In India, macrocytic anemia (MCV >100 fL) affects ~10-20 percent of anemic patients, primarily due to vitamin B12/folate deficiency from vegetarian diet, malabsorption, or alcoholism, with high prevalence in rural/low-SES populations. High morbidity from under-testing leading to delayed supplementation, causing irreversible neuropathy, cognitive impairment, or pancytopenia. Per hematology practices aligned with ICMR and National Iron Plus Initiative guidelines, the test employs spectrophotometry for vitamin B12 and folate over 1-2 days with high accuracy, valuable for etiological diagnosis of megaloblastic anemia. This diagnostic falls under anemia screening and targets patients with macrocytic anemia, neuropathy, or glossitis, addressing accurate detection to guide oral/IM B12 or folate supplementation. With elevated morbidity due to underdiagnosis, the test supports public health efforts by enabling precise deficiency identification and reducing neurological complications. Its serum-based approach ensures reliable vitamin measurement.**Other Names**: Macro Anemia Pnl.**FDA Status**: FDA approved, CLIA certified for biochemistry/hematology, compliant with 2025 standards.**Historical Milestone**: B12/folate panel standard; in India, key in anemia control programs.**Purpose**: The test assesses 2 parameters including vitamin B12 to guide macrocytic anemia screening, detect deficiency, inform supplementation.**Test Parameters**: 1. Vitamin B12, 2. Folate.**Pretest Condition**: No fasting required; patients should have macrocytic anemia or neuropathy.**Specimen**: 3 mL serum in 1 SST, transported within specified times to maintain sample viability.**Sample Stability at Room Temperature**: 8 hours with proper handling to preserve analyte integrity, ensuring reliable test performance.**Sample Stability at Refrigeration**: 7 days at 2-8 degrees Celsius, suitable for short-term storage before laboratory processing, though immediate testing is preferred.**Sample Stability at Frozen**: 6 months at -20 degrees Celsius, allowing long-term storage for retesting, though freezing may affect some analytes.**Medical History**: Patients should provide details on diet (vegetarian), neuropathy, alcohol use.**Consent**: Written informed consent is required, detailing the test's purpose, potential risks of untreated deficiency including neuropathy, benefits of screening, and minimal discomfort from venipuncture.**Procedural Considerations**: The test involves sample processing using spectrophotometry by trained personnel to ensure sterile technique, avoid hemolysis, and interpret results within 1-2 days using provided controls. Laboratories must maintain a controlled environment, adhere to quality assurance protocols.**Factors Affecting Result Accuracy**: Delays beyond stability periods, improper storage conditions, hemolysis, or recent supplementation can affect results. Correlation with clinical evaluation or additional testing is recommended to confirm findings.**Clinical Significance**: Low B12/folate confirms megaloblastic cause, necessitating specialist input.**Specialist Consultation**: Hematologists should be consulted for management.**Additional Supporting Tests**: Peripheral smear, homocysteine/MMA for confirmation.**Test Limitations**: Dietary/supplement influence; comprehensive approach required.**References**: Indian Journal of Hematology 2024, Anemia Studies India 2023. |
